News | December 08, 2008

Slower Heart Rate May Translate into Longer Life

December 9, 2008 - Slowing heart rate with exercise and stress reduction may help extend life, reports the December 2008 issue of the Harvard Heart Letter.

Sixty years ago, researchers showed that men with fast resting heart rates were more likely to develop high blood pressure than those with slower rates. Since then, a high resting heart rate has been linked to atherosclerosis, sudden death, and an increased risk of dying from cardiovascular disease. The article states each pulse of blood puts a mild stress on artery walls. More beats per minute means more stress. A faster heartbeat also gives the coronary arteries less time to fill with blood. This can lead to an imbalance between heart cells’ demand for oxygen and the heart’s ability to provide it.

Resting heart rate seems to be a common denominator for various types of heart disease. A tantalizing possibility is that lowering your heart rate could help protect you from heart disease and may even let your heart beat for longer.

The Harvard Heart Letter notes that if a resting heart rate is high, patients can do something about it by exercising more and reducing stress. Exercising every day gradually slows the resting rate. The relaxation response, meditation, and other stress-busting techniques also lower heart rate over time.

For more information: www.health.harvard.edu/heart


Related Content

News | Cardiovascular Clinical Studies

March 4, 2026 — UltraSight, a provider of AI-guided cardiac imaging workflows, has announced Late-Breaking clinical ...

Home March 04, 2026
Home
News | Cardiovascular Clinical Studies

Feb. 9, 2026 — HTA and MedAxiom have opened applications for the 2026 HeartX program, a cardiovascular-focused ...

Home February 18, 2026
Home
News | Cardiovascular Clinical Studies

Jan. 5, 2026 — Medera Inc., a clinical-stage biopharmaceutical company focused on targeting cardiovascular diseases by ...

Home January 05, 2026
Home
News | Cardiovascular Clinical Studies

Nov. 10, 2025 —Genomics, a science-led techbio company, has today announced new research that suggests polygenic risk ...

Home November 12, 2025
Home
News | Cardiovascular Clinical Studies

Oct. 21, 2025 – AskBio Inc., a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG ...

Home October 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 25, 2025 — Merck, known as MSD outside of the United States and Canada, has announced that new clinical trial and ...

Home August 25, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 18, 2025 — (Newswise) It’s often mistaken for a heart attack, but Takotsubo cardiomyopathy — previously known as ...

Home August 21, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 20, 2025 — A major international study published in Atherosclerosis* has found that routinely testing for ...

Home August 20, 2025
Home
News | Cardiovascular Clinical Studies

Aug. 4, 2025 — Marea Therapeutics, Inc., a clinical-stage biotechnology company that develops next-generation medicines ...

Home August 04, 2025
Home
News | Cardiovascular Clinical Studies

July 16, 2025 — Medtronic has announced that the first patient has been enrolled in the PEripheral Onyx Liquid Embolic ...

Home July 22, 2025
Home
Subscribe Now